Position in BLLN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,003,090
+$991,142 QoQ
Shares Held
12,707
+8603.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $6,863,803,811 across 34 Diagnostics & Research names. BLLN ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,533,403 | $2,719,833,571 | |
| 2 | DHR |
Danaher Corp /De/
|
6,252,116 | $1,185,401,190 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,752,902 | $343,533,731 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
488,017 | $274,211,867 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
207,286 | $261,429,102 | |
| 6 | WAT |
Waters Corp /De/
|
843,636 | $251,234,797 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,299,122 | $221,552,262 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,135,027 | $195,792,156 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,003,090 | 12,707 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $11,948 | 146 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||